Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Almac, Saltigo Boost High-Potency Plants
by Michael McCoy
October 31, 2011
| A version of this story appeared in
Volume 89, Issue 44
Almac will expand active pharmaceutical ingredient (API) manufacturing capacity at its headquarters in Craigavon, Northern Ireland. The firm says the expansion, to more than 30 m3, will include reactor vessels allowing highly potent API production in batches of up to 600 kg. It expects the facility to be built, commissioned, and validated within the next two years. Saltigo, meanwhile, will expand its Redmond, Wash., site to handle highly potent compounds. Capacities up to the kilogram range will be available early next year, the firm says.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X